← Leaderboards
Gillian L Beamer
Ohio State University
$6,255,250
Attributed
$6,564,768
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2007–24$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,564,768 · 5
By mechanism
R01$3,357,574 · 1
R61$1,615,572 · 1
R56$619,036 · 1
K08$491,615 · 1
R21$480,971 · 1
Top collaborators
- Antonio Campos-Neto1 shared
Most similar at Ohio State University
Same institution · by research overlap
- Junran Zhang$6,141,970
- Nancy E Moran$2,734,695
- Kamal D Mehta$4,546,237
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisMycobacterium TuberculosisInfectionResponseLungPredispositionGranulomaPathogenBaseImmuneGenotypeMorbidity - Disease RateTransmission ProcessPulmonary TuberculosisProductionImmunityResistanceTrainingAnimal ModelInbred StrainDatabasesProteinsAntigensCells
Grant awards (15)
Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis$532,829
R61 · FY2024 · AI · contact PI
Predicting tuberculosis outcomes using genotypic and biomarker signatures$802,668
R01 · FY2023 · HL · contact PI
Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis$526,177
R61 · FY2023 · AI · contact PI
Predicting tuberculosis outcomes using genotypic and biomarker signatures$659,272
R01 · FY2022 · HL · contact PI
Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis$556,566
R61 · FY2022 · AI · contact PI
Predicting tuberculosis outcomes using genotypic and biomarker signatures$623,092
R01 · FY2021 · HL · contact PI
Predicting tuberculosis outcomes using genotypic and biomarker signatures$655,091
R01 · FY2020 · HL · contact PI
Predicting tuberculosis outcomes using genotypic and biomarker signatures$617,451
R01 · FY2019 · HL · contact PI
Genetic-based susceptibility to pulmonary tuberculosis$217,661
R21 · FY2016 · AI · contact PI
Genetic-based susceptibility to pulmonary tuberculosis$263,310
R21 · FY2015 · AI · contact PI
Mesenchynmal stem cells as a protective niche for latent M. tuberculosis$619,036
R56 · FY2014 · AI
Chemokines and their receptors in the pathogenesis of tuberculosis$130,748
K08 · FY2010 · AI · contact PI
Chemokines and their receptors in the pathogenesis of tuberculosis$127,726
K08 · FY2009 · AI · contact PI
Chemokines and their receptors in the pathogenesis of tuberculosis$124,356
K08 · FY2008 · AI · contact PI
Chemokines and their receptors in the pathogenesis of tuberculosis$108,785
K08 · FY2007 · AI · contact PI